drugset
Drugs / Omicron COVID-19 Vaccine (Vero Cell), Inactivated
last change Nov 2023 re-read 2 minutes ago

Omicron COVID-19 Vaccine (Vero Cell), Inactivated

Vaccine

Developed for
COVID-19
Investigated by
Beijing Institute of Biological Products Co Ltd. · China National Biotec Group Company Limited · Hunan Provincial Center for Disease Control and Prevention · Shulan (Hangzhou) Hospital

Trials 2 · a red edge is where a trial was stopped

today NCT05374954 · Ph 3 NCT05365724 · Ph 1/2
2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/21 trial
Phase 1/2 NCT05365724 May 2022 → Oct 2023 COVID-19 China National Biotec Group Company Limited Unknown No outcome recorded
Phase 31 trial
Phase 3 NCT05374954 May → Sep 2022 COVID-19 China National Biotec Group Company Limited Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Omicron COVID-19 Vaccine (Vero Cell), Inactivated ClinicalTrials.gov intervention name — accepted as the source's own label NCT05374954 ↗
1

NCT05365724 ↗
Modality Vaccine “Omicron COVID-19 Vaccine (Vero Cell), Inactivated” NCT05374954 ↗